Supply Chain

Pomona, Calif.-based CLR Medicals International has issued a nationwide recall on its Viscocel and Viscocel Plus products.

Janssen Therapeutics, a division of Janssen Products, announced that the U.S. Food and Drug Administration approved OLYSIO (simeprevir), an NS3/4A protease inhibitor.

The U.S. Food and Drug Administration issued a warning letter to 23andMe to stop marketing and selling the company's Saliva Collection Kit and Personal Genome Service, saying the PGS had not received approval from the FDA.

Mansfield, Mass.-based Covidien plans to open an $18 million production facility in Hillsborough County, Fla., according to a Plastics News report.

MediPurpose, a Singapore-based medical device manufacturer and distributor, has entered a private label deal with EKF Diagnostics for MediPurpose's SurgiLance safety lancet, according to a MediPurpose news release.

IbisWorld, a business industry research firm, projects the medical instrument and supply manufacturing industry will continue to grow at a steady pace for the next five years.

OrthAlign, a privately held medical device company, announced it has received 510(k) clearance from the United States Food and Drug Administration to market its ORTHALIGN PLUS system.

Collaboration and accountability are evolving as the new pillars of the U.S. healthcare system. Yet they will not stand the test of time without the support of an increasingly sophisticated healthcare value chain that unites providers and suppliers as efficiently…

The U.S. Food and Drug Administration has announced its approval for an implantable device that decreases the number of seizures for patients with drug-resistant epilepsy.

The market for pre-owned medical devices is expected to grow by a compound annual growth rate of 10.6 percent from 2013 until 2019, bringing the market value to $4.9 billion, according to a news release.